Fundz

Technology-Driven Precision Medicine Company Variantyx Secures $41.5M In Funding

PRIVATEFeb 14, 2022

Amount Raised

$41.5 Million

Round Type

Funding Round

FraminghamInformation TechnologyBiotechnologyCommunity And LifestyleHealth CareScience And Engineering

Description

Variantyx, a technology-driven precision medicine company providing advanced genomic testing for the rare genetic disorders, reproductive health, and precision oncology markets, today announced they have secured $41.5M in funding. The series C-2 funding round, led by New Era Capital Partners and includes Peregrine Ventures, Robert Bosch Venture Capital, 20/20 HealthCare Partners, and Pitango HealthTech, will be used to fuel company growth and launch newly developed solutions across all markets, with a focus on precision oncology.

Quick answer

Variantyx raised $41.5 Million in a Funding Round round, dated February 14, 2022. Variantyx is based in Framingham, Massachusetts, United States.

How much did Variantyx raise?
Variantyx raised $41.5 Million in a Funding Round round on February 14, 2022.
What does Variantyx do?
Variantyx is a technology-driven precision medicine company providing disruptive solutions for the genetic disorders, reproductive health, and precision oncology markets.
Where is Variantyx based and how big is it?
Variantyx is based in Framingham, Massachusetts, United States.
Who are the decision-makers at Variantyx?
Fundz holds 1 contact at Variantyx, including the CEO. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Community And Lifestyle and Science And Engineering around the same time

Companies in the same sectors as Variantyx that raised within 45 days of this round, from Fundz verified event records.

  • 2seventy bio raised $170M on March 31, 2022.
  • Zephyr AI, Inc. raised $19M (Seed) on March 30, 2022.
  • Geneos Therapeutics raised $17M on March 28, 2022.
  • Geneos Therapeutics raised $17M (Series A) on March 24, 2022.
  • Nucleai raised $33M (Series B) on March 22, 2022.
  • Theriva Biologics raised $1.5M (Seed) on March 21, 2022.

Who to call at Variantyx, and when

A new round usually means Variantyx is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Variantyx raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Variantyx, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Variantyx. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Variantyx

Location

Framingham, Massachusetts, United States

About

Variantyx is a technology-driven precision medicine company providing disruptive solutions for the genetic disorders, reproductive health, and precision oncology markets. The proprietary whole genome analysis platforms developed by Variantyx allow clinicians and patients to better understand a person's genetic makeup, leading to unmatched diagnostic capabilities and improved personalized treatment recommendations.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Variantyx raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts Haim N., CEO hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Variantyx's next move

See what Strategic adds

Variantyx raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.